|Articles|October 24, 2011

Impact - THE CASE FOR UPGRADING EXISTING HPLC ASSAYS TO UPLC

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Trending on Pharmaceutical Technology

Impact - THE CASE FOR UPGRADING EXISTING HPLC ASSAYS TO UPLC

Trending on Pharmaceutical Technology

Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics

FDA Approves Pfizer’s Breast Cancer Treatment

Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value

Pharma Fundamentals: Hold Times in Biopharmaceuticals

Q&A: Why Pharma Deal Volume Is Down but Value Is Up